ClinicalTrials.Veeva

Menu

The Role of Intravitreal Glucose in Macular Thinning Following Surgery for Retinal Detachment or Epimacular Membrane (GLU-MAC)

C

CHU de Reims

Status

Completed

Conditions

Vitrectomy
Macular Thinning

Study type

Observational

Funder types

Other

Identifiers

NCT02210481
AOL2010-02

Details and patient eligibility

About

Comparison between intravitreous glucose rate and macular thinning measured by Ocular Coherence Tomography (OCT) at 3 months post vitrectomy for retinal detachment or epimacular membrane. Hypothesis : Association between post-operative macular thickness and intravitreous glucose rate

Full description

Comparison between intravitreous glucose rate and macular thinning measured by OCT at 3 months post vitrectomy for retinal detachment or epimacular membrane. The cohort is divided in 2 groups, one with the thinnest macular measurement under 190µm, and the others above 190µm. We are looking for a correlation between increasing glucose rates and decreased macular thickness.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient who underwent vitrectomy for retinal detachment or epimacular membrane

Exclusion criteria

  • patient suffering of diabetes,
  • recurrence of retinal detachment,
  • age-related macular degeneration,
  • post surgical macular oedema

Trial design

60 participants in 1 patient group

GLUC-MAC-COHORT
Description:
post vitrectomy for retinal detachment or epimacular membrane patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems